Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Morabito

Showing results (81-90 of 198) with videos related to

Pageof 20
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Cancers|January 26, 2021
Surgery in Small-Cell Lung CancerNicola Martucci, Alessandro Morabito, Antonello La Rocca, et al.
Cancer Treatment Reviews|July 24, 2012
Treatment of pulmonary neuroendocrine tumours: state of the art and future developmentsCesare Gridelli, Antonio Rossi, Giuseppe Airoma, et al.
Clinical Lung Cancer|May 23, 2016
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung CancerCesare Gridelli, Antonio Rossi, Fortunato Ciardiello, et al.
Translational Lung Cancer Research|March 25, 2020
Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implicationsRaffaella Pasquale, Laura Forgione, Cristin Roma, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancerMassimo Di Maio, Raffaele Costanzo, Pasqualina Giordano, et al.
Future Oncology (London, England)|October 20, 2018
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational studyMaximilian J Hochmair, Alessandro Morabito, Desiree Hao, et al.
Future Oncology (London, England)|June 5, 2015
EGFR mutations in lung cancer: from tissue testing to liquid biopsyFrancesca Fenizia, Antonella De Luca, Raffaella Pasquale, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 21, 2024
Cross-reactive CD8<sup>+</sup> T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)Beatrice Cavalluzzo, Marie Christine Viuff, Siri Amanda Tvingsholm, et al.
Pageof 20

Showing results (81-90 of 198) with videos related to

Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|June 3, 2014
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancerNicola Normanno, Antonio Rossi, Alessandro Morabito, et al.
Cancers|January 26, 2021
Surgery in Small-Cell Lung CancerNicola Martucci, Alessandro Morabito, Antonello La Rocca, et al.
Cancer Treatment Reviews|July 24, 2012
Treatment of pulmonary neuroendocrine tumours: state of the art and future developmentsCesare Gridelli, Antonio Rossi, Giuseppe Airoma, et al.
Clinical Lung Cancer|May 23, 2016
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung CancerCesare Gridelli, Antonio Rossi, Fortunato Ciardiello, et al.
Translational Lung Cancer Research|March 25, 2020
Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implicationsRaffaella Pasquale, Laura Forgione, Cristin Roma, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancerMassimo Di Maio, Raffaele Costanzo, Pasqualina Giordano, et al.
Future Oncology (London, England)|October 20, 2018
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational studyMaximilian J Hochmair, Alessandro Morabito, Desiree Hao, et al.
Future Oncology (London, England)|June 5, 2015
EGFR mutations in lung cancer: from tissue testing to liquid biopsyFrancesca Fenizia, Antonella De Luca, Raffaella Pasquale, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 21, 2024
Cross-reactive CD8<sup>+</sup> T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)Beatrice Cavalluzzo, Marie Christine Viuff, Siri Amanda Tvingsholm, et al.
Pageof 20